Stockreport

Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress

Aurinia Pharmaceuticals Inc - Common Shares  (AUPH) 
Last aurinia pharmaceuticals inc - common shares earnings: 3/5 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.auriniapharma.com
PDF Third Quarter 2025 LUPKYNIS Sales Grew 27%LUPKYNIS Sales Guidance for 2025 Raised to $265 Million to $270 MillionAritinercept Advances Toward Clinical Studies in Two Aut [Read more]